IDEXX LABORATORIES INC /DE Total Long-Term Debt
IDEXX LABORATORIES INC /DE (IDXX) had Total Long-Term Debt of $450.00 million as of 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-02-20
- 2025-12-31: Long-term Debt $450.00M.
- 2024-12-31: Long-term Debt $617.80M.
- 2023-12-31: Long-term Debt $698.19M.
- 2022-12-31: Long-term Debt $769.77M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2025-12-31 | $450.00M 10-K · filed 2026-02-20 | |
| 2024-12-31 | $617.80M 10-K · filed 2025-02-21 | |
| 2023-12-31 | $698.19M 10-K · filed 2024-02-22 | |
| 2022-12-31 | $769.77M 10-K · filed 2023-02-16 | |
| 2021-12-31 | $850.71M 10-K · filed 2022-02-16 | |
| 2020-12-31 | $909.10M 10-K · filed 2022-02-16 | $909.13M 10-K · filed 2021-02-12 |
| 2019-12-31 | $699.40M 10-K · filed 2021-02-12 | $699.42M 10-K · filed 2020-02-14 |
| 2018-12-31 | $601.80M 10-K · filed 2020-02-14 | $601.78M 10-K · filed 2019-02-15 |
| 2017-12-31 | $606.60M 10-K · filed 2019-02-15 | $606.57M 10-K · filed 2018-02-16 |
| 2016-12-31 | $593.70M 10-K · filed 2018-02-16 | $593.66M 10-K · filed 2017-02-17 |
| 2015-12-31 | $597.10M 10-K · filed 2017-02-17 | $597.09M 10-K · filed 2016-02-17 |
| 2014-12-31 | $350.00M 10-K · filed 2015-02-17 | |
| 2013-12-31 | $151.39M 10-K · filed 2014-02-18 | |
| 2012-12-31 | $2.50M 10-K · filed 2013-02-19 | |
| 2011-12-31 | $3.42M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |